Drug recall D-0486-2021
Product
Triumeq (abacavir, dolutegravir, and lamivudine) 600 mg/50 mg/300 mg Tablets 30 Tablets Rx Only NDC 49702-231-13 Manufactured for: Viiv Healthcare Research Triangle Park, NC 27709 by GlaxoSmithKline Research Triangle Park, NC 27709
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
GS5G
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 2264 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Triumeq – drug information
- NDC 49702-231 Triumeq · Abacavir Sulfate 600 mg/1; Dolutegravir Sodium 50 mg/1;… · ViiV Healthcare Company
- NDC 49702-258 Triumeq PD · · ViiV Healthcare Company